Re: Clover et al. Transformation of a non-secretory neuro-endocrine tumor to insulinoma after treatment with Sunitinib: a case report and review of the literature. J Oncol Pharm Pract 2018. DOI: 10.1177/1078155218791309 Sunitinib-associated hyperinsulinem

Fountas, A; Tigas, S

Fountas, A (reprint author), Univ Hosp Ioannina, Dept Endocrinol, Ioannina, Greece.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (4): 1026